Cobimetinib Products | Cleanchem - Cobimetinib is a targeted therapy drug used to treat melanoma in combination with vemurafenib, particularly in patients with BRAF V600E or V600K mutations. It works by inhibiting MEK1/2, enzymes in the MAPK pathway that are involved in cell proliferation and survival. Cobimetinib is often used in advanced or metastatic melanoma treatment. Side effects may include diarrhea, nausea, and skin rash.

Cat. No: CL-CBMT-01

CAS No: 934660-93-2

Mol. F: C21H21F3IN3O2

Mol. Wt: 531.3

Inv. Status: Custom Synthesis

Cat. No: CL-CBMT-02

CAS No: 2714409-22-8

Mol. F: C21H12D9F3IN3O2

Mol. Wt: 540.4

Inv. Status: Custom Synthesis

Cat. No: CL-CBMT-03

CAS No: 1597407-56-1

Mol. F: C21H32N2O4

Mol. Wt: 376.5

Inv. Status: Custom Synthesis

Cat. No: CL-CBMT-04

CAS No: 1597407-58-3

Mol. F: C23H25F3N2O3

Mol. Wt: 434.5

Inv. Status: Custom Synthesis

Cat. No: CL-CBMT-05

CAS No: 2065147-70-6

Mol. F: C15H17F3N2O2 : HCl

Mol. Wt: 314.3 : 36.5

Inv. Status: Custom Synthesis

Cat. No: CL-CBMT-06

CAS No: 934660-94-3

Mol. F: C21H21F3IN3O2

Mol. Wt: 531.3

Inv. Status: Custom Synthesis

Cat. No: CL-CBMT-07

CAS No: 934662-91-6

Mol. F: C21H21F3IN3O2

Mol. Wt: 531.3

Inv. Status: Custom Synthesis